USPH Historical Income Statement

USPH Stock

USD 97.08 1.52 1.54%

Historical analysis of US Physicalrapy income statement accounts such as Interest Expense of 9.8 M, Total Revenue of 635 M, Gross Profit of 117.6 M or Other Operating Expenses of 562 M can show how well US Physicalrapy performed in making a profits. Evaluating US Physicalrapy income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of US Physicalrapy's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining US Physicalrapy latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether US Physicalrapy is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

About USPH Income Statement Analysis

US Physicalrapy Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to US Physicalrapy shareholders. The income statement also shows USPH investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

US Physicalrapy Income Statement Chart

As of now, US Physicalrapy's Other Operating Expenses is increasing as compared to previous years. The US Physicalrapy's current Operating Income is estimated to increase to about 73 M, while EBIT is projected to decrease to under 31.5 M.

Total Revenue Gross Profit Other Operating Expenses Cost Of Revenue Income Tax Expense Depreciation And Amortization

Total Revenue

Total revenue comprises all receipts US Physicalrapy generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of US Physicalrapy minus its cost of goods sold. It is profit before US Physicalrapy operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of US Physicalrapy. It is also known as US Physicalrapy overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on US Physicalrapy income statement and represents the costs associated with goods and services US Physicalrapy provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Most accounts from US Physicalrapy's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into US Physicalrapy current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.As of now, US Physicalrapy's Other Operating Expenses is increasing as compared to previous years. The US Physicalrapy's current Operating Income is estimated to increase to about 73 M, while EBIT is projected to decrease to under 31.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	117.2M	112.0M	112.0M	117.6M
Total Revenue	495.0M	553.1M	604.8M	635.0M

Gross Profit Total Revenue

US Physicalrapy income statement Correlations

	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Net Income	Income Tax Expense	Depreciation And Amortization	Income Before Tax	Total Other Income Expense Net	Selling General Administrative	Minority Interest	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Discontinued Operations	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items	Selling And Marketing Expenses
Interest Expense		0.42	0.33	0.43	0.33	0.14	0.17	0.43	0.23	-0.1	-0.29	0.39	-0.17	-0.83	0.23	-0.3	-0.18	0.2	-0.23	0.32	-0.85	-0.48	-0.47	0.25	-0.33	-0.33
Total Revenue	0.42		0.96	1.0	0.94	0.69	0.72	1.0	0.75	0.45	0.43	0.97	0.62	-0.39	0.82	-0.53	0.61	0.56	-0.05	0.54	-0.17	-0.65	0.47	0.7	-0.55	-0.55
Gross Profit	0.33	0.96		0.95	0.98	0.82	0.84	0.95	0.85	0.58	0.59	0.93	0.77	-0.23	0.88	-0.38	0.66	0.47	-0.09	0.35	-0.13	-0.68	0.51	0.55	-0.37	-0.37
Other Operating Expenses	0.43	1.0	0.95		0.93	0.66	0.7	1.0	0.73	0.42	0.4	0.97	0.59	-0.41	0.81	-0.55	0.6	0.57	-0.06	0.56	-0.18	-0.64	0.46	0.72	-0.57	-0.57
Operating Income	0.33	0.94	0.98	0.93		0.79	0.81	0.93	0.81	0.54	0.58	0.9	0.74	-0.29	0.84	-0.42	0.65	0.52	-0.15	0.4	-0.09	-0.65	0.49	0.5	-0.42	-0.42
Ebit	0.14	0.69	0.82	0.66	0.79		1.0	0.65	0.91	0.76	0.75	0.65	0.94	0.14	0.94	-0.02	0.65	0.2	0.04	0.0	-0.13	-0.7	0.5	0.26	0.18	0.18
Ebitda	0.17	0.72	0.84	0.7	0.81	1.0		0.69	0.93	0.75	0.73	0.7	0.93	0.09	0.96	-0.06	0.66	0.23	0.02	0.06	-0.14	-0.72	0.51	0.33	0.14	0.14
Cost Of Revenue	0.43	1.0	0.95	1.0	0.93	0.65	0.69		0.72	0.41	0.38	0.97	0.58	-0.42	0.8	-0.56	0.6	0.58	-0.04	0.57	-0.18	-0.64	0.46	0.73	-0.59	-0.59
Total Operating Expenses	0.23	0.75	0.85	0.73	0.81	0.91	0.93	0.72		0.58	0.7	0.72	0.83	-0.08	0.93	-0.15	0.53	0.28	-0.25	0.12	-0.21	-0.63	0.39	0.4	0.08	0.08
Net Income	-0.1	0.45	0.58	0.42	0.54	0.76	0.75	0.41	0.58		0.57	0.52	0.8	0.41	0.64	0.0	0.73	-0.08	0.25	-0.23	0.2	-0.57	0.57	0.18	0.22	0.22
Income Tax Expense	-0.29	0.43	0.59	0.4	0.58	0.75	0.73	0.38	0.7	0.57		0.38	0.82	0.32	0.66	0.07	0.36	0.29	-0.13	-0.05	0.35	-0.16	0.45	0.1	0.19	0.19
Depreciation And Amortization	0.39	0.97	0.93	0.97	0.9	0.65	0.7	0.97	0.72	0.52	0.38		0.6	-0.35	0.79	-0.49	0.66	0.5	-0.04	0.53	-0.12	-0.66	0.5	0.7	-0.54	-0.54
Income Before Tax	-0.17	0.62	0.77	0.59	0.74	0.94	0.93	0.58	0.83	0.8	0.82	0.6		0.37	0.86	0.04	0.77	0.17	0.1	-0.06	0.17	-0.58	0.71	0.21	0.17	0.17
Total Other Income Expense Net	-0.83	-0.39	-0.23	-0.41	-0.29	0.14	0.09	-0.42	-0.08	0.41	0.32	-0.35	0.37		-0.06	0.57	0.31	-0.48	0.45	-0.64	0.57	0.13	0.47	-0.4	0.62	0.62
Selling General Administrative	0.23	0.82	0.88	0.81	0.84	0.94	0.96	0.8	0.93	0.64	0.66	0.79	0.86	-0.06		-0.24	0.67	0.38	0.02	0.29	-0.17	-0.71	0.54	0.53	-0.04	-0.04
Minority Interest	-0.3	-0.53	-0.38	-0.55	-0.42	-0.02	-0.06	-0.56	-0.15	0.0	0.07	-0.49	0.04	0.57	-0.24		-0.18	-0.42	0.08	-0.67	-0.07	0.13	-0.15	-0.82	0.66	0.66
Net Income From Continuing Ops	-0.18	0.61	0.66	0.6	0.65	0.65	0.66	0.6	0.53	0.73	0.36	0.66	0.77	0.31	0.67	-0.18		0.06	0.35	0.13	0.24	-0.65	0.89	0.37	-0.13	-0.13
Non Recurring	0.2	0.56	0.47	0.57	0.52	0.2	0.23	0.58	0.28	-0.08	0.29	0.5	0.17	-0.48	0.38	-0.42	0.06		-0.29	0.67	-0.02	0.0	0.1	0.49	-0.57	-0.57
Non Operating Income Net Other	-0.23	-0.05	-0.09	-0.06	-0.15	0.04	0.02	-0.04	-0.25	0.25	-0.13	-0.04	0.1	0.45	0.02	0.08	0.35	-0.29		0.03	0.15	-0.15	0.39	0.12	-0.01	-0.01
Discontinued Operations	0.32	0.54	0.35	0.56	0.4	0.0	0.06	0.57	0.12	-0.23	-0.05	0.53	-0.06	-0.64	0.29	-0.67	0.13	0.67	0.03		-0.05	-0.03	0.12	0.73	-0.8	-0.8
Tax Provision	-0.85	-0.17	-0.13	-0.18	-0.09	-0.13	-0.14	-0.18	-0.21	0.2	0.35	-0.12	0.17	0.57	-0.17	-0.07	0.24	-0.02	0.15	-0.05		0.41	0.53	0.01	-0.03	-0.03
Interest Income	-0.48	-0.65	-0.68	-0.64	-0.65	-0.7	-0.72	-0.64	-0.63	-0.57	-0.16	-0.66	-0.58	0.13	-0.71	0.13	-0.65	0.0	-0.15	-0.03	0.41		-0.45	-0.28	0.03	0.03
Net Interest Income	-0.47	0.47	0.51	0.46	0.49	0.5	0.51	0.46	0.39	0.57	0.45	0.5	0.71	0.47	0.54	-0.15	0.89	0.1	0.39	0.12	0.53	-0.45		0.37	-0.11	-0.11
Reconciled Depreciation	0.25	0.7	0.55	0.72	0.5	0.26	0.33	0.73	0.4	0.18	0.1	0.7	0.21	-0.4	0.53	-0.82	0.37	0.49	0.12	0.73	0.01	-0.28	0.37		-0.56	-0.56
Extraordinary Items	-0.33	-0.55	-0.37	-0.57	-0.42	0.18	0.14	-0.59	0.08	0.22	0.19	-0.54	0.17	0.62	-0.04	0.66	-0.13	-0.57	-0.01	-0.8	-0.03	0.03	-0.11	-0.56		1.0
Selling And Marketing Expenses	-0.33	-0.55	-0.37	-0.57	-0.42	0.18	0.14	-0.59	0.08	0.22	0.19	-0.54	0.17	0.62	-0.04	0.66	-0.13	-0.57	-0.01	-0.8	-0.03	0.03	-0.11	-0.56	1.0

Click cells to compare fundamentals

US Physicalrapy Account Relationship Matchups

US Physicalrapy income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	2.1M	1.6M	942K	5.8M	9.3M	9.8M
Total Revenue	482.0M	423.0M	495.0M	553.1M	604.8M	635.0M
Gross Profit	112.5M	94.5M	117.2M	112.0M	112.0M	117.6M
Other Operating Expenses	414.5M	357.1M	419.8M	487.2M	535.2M	562.0M
Operating Income	67.4M	52.4M	76.8M	56.8M	69.6M	73.0M
Ebit	67.4M	67.1M	74.1M	61.4M	58.7M	31.5M
Ebitda	83.1M	77.7M	85.7M	76.1M	74.4M	37.7M
Cost Of Revenue	369.5M	328.5M	377.8M	441.1M	492.8M	517.5M
Total Operating Expenses	45.0M	28.5M	41.9M	46.1M	42.4M	23.1M
Net Income	57.3M	52.5M	57.9M	43.4M	14.7M	15.6M
Income Tax Expense	13.6M	13.0M	15.3M	12.2M	12.2M	7.7M
Depreciation And Amortization	15.7M	10.5M	11.6M	14.7M	15.7M	16.5M
Income Before Tax	70.9M	65.5M	73.2M	55.6M	49.4M	31.9M
Total Other Income Expense Net	3.5M	13.1M	2.5M	(1.2M)	(20.2M)	(19.2M)
Selling General Administrative	45.0M	42.0M	46.5M	46.1M	52.0M	26.7M
Net Income Applicable To Common Shares	40.0M	35.2M	40.8M	29.3M	33.7M	19.8M
Minority Interest	17.2M	17.3M	(17.1M)	(11.2M)	(20.4M)	(19.3M)
Net Income From Continuing Ops	57.3M	52.5M	57.9M	43.4M	41.9M	42.3M
Non Operating Income Net Other	1.9M	46K	13.1M	2.5M	2.9M	2.3M
Interest Income	46K	142K	199K	859K	3.1M	3.2M
Net Interest Income	(2.0M)	(1.5M)	(743K)	(4.9M)	(6.5M)	(6.8M)
Reconciled Depreciation	10.1M	10.5M	11.6M	14.7M	15.4M	12.9M

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:

How To Invest In USPH

Details

Is USPH Stock a good investment?

Details

What is US Physicalrapy's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.24)

Dividend Share

1.75

Earnings Share

0.88

Revenue Per Share

42.489

Quarterly Revenue Growth

0.12

The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

USPH Historical Income Statement

About USPH Income Statement Analysis

US Physicalrapy Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Cost Of Revenue

Depreciation And Amortization

US Physicalrapy income statement Correlations

US Physicalrapy Account Relationship Matchups

High Positive Relationship

High Negative Relationship

US Physicalrapy income statement Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Selling And Marketing Expenses	+ 1.0	Extraordinary Items
Operating Income	+ 0.98	Gross Profit

Tax Provision	- 0.85	Interest Expense
Total Other Income Expense Net	- 0.83	Interest Expense
Reconciled Depreciation	- 0.82	Minority Interest
Selling And Marketing Expenses	- 0.8	Discontinued Operations
Extraordinary Items	- 0.8	Discontinued Operations
Interest Income	- 0.72	Ebitda